脑萎缩对机械取栓结局的影响
该系统综述检索4个数据库至2021年3月,纳入4篇评估预先存在脑萎缩对机械取栓治疗大血管闭塞性急性缺血性卒中结局影响的英文文献。脑萎缩指数可预测死亡(OR 1.81-1.87,95%CI 1.16-2.93),全局皮质萎缩量表可独立预测无效再通(OR 1.15,95%CI 1.08-1.22),脑脊液自动测量容量增加与3个月功能独立降低和改良Rankin量表评分升高相关。作者认为现有研究异质性大,需更一致准确的研究后才能将脑萎缩作为改善患者选择的参数。
要点
- 脑萎缩指数经年龄和白质病变校正后可预测机械取栓后死亡(OR 1.81-1.87)。
- 全局皮质萎缩量表是多变量校正后无效再通的独立预测因子(OR 1.15)。
- 脑脊液自动测量容量增加与3个月功能独立降低和改良Rankin评分升高相关。
核心结论
- 现有少数研究显示脑萎缩与机械取栓后死亡、无效再通和功能结局相关,但神经影像评估方法异质性和多重混杂因素使脑萎缩作为患者选择参数前需更一致准确的研究。
研究设计与样本
- 系统文献综述,检索PubMed、MEDLINE、EMBASE和Cochrane Library数据库自建库至2021年3月,纳入4篇英文文献。
关键影像表现/征象
- 脑萎缩指数经年龄和白质病变校正后可预测死亡(OR 1.81-1.87,95%CI 1.16-2.93)。
- 全局皮质萎缩量表在多变量校正逻辑回归中是无效再通的独立预测因子(OR 1.15,95%CI 1.08-1.22)。
- 脑脊液自动测量显示容量增加与3个月功能独立降低和改良Rankin量表评分升高相关。
- STandards for ReportIng Vascular changes on Neuroimaging标准评估的脑萎缩在序数位移分析中与不良结局相关(OR 2.72,95%CI 1.25-5.91)。
诊断标准与关键数值
- 脑萎缩指数预测死亡:OR 1.81-1.87,95%CI 1.16-2.93(经年龄和白质病变校正)。
- 全局皮质萎缩量表预测无效再通:OR 1.15,95%CI 1.08-1.22(多变量校正逻辑回归)。
- STandards for ReportIng Vascular changes on Neuroimaging标准评估脑萎缩与不良结局:OR 2.72,95%CI 1.25-5.91(序数位移分析)。
临床应用与阅片要点
- 作者认为现有研究异质性大且混杂因素复杂,需更一致准确的研究后才能将脑萎缩作为改善机械取栓患者选择的可能参数。
- 脑萎缩与急性缺血性卒中患者常见的多种临床混杂因素相关,评估其对取栓结局的真实影响存在困难。
局限性
- 仅4篇文献被纳入。
- 脑萎缩神经影像评估方法存在异质性。
- 临床结局涉及多重混杂因素,分析复杂。
- 需更一致准确的研究后才能提议将脑萎缩作为改善机械取栓患者选择的参数。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: Pre-existing brain atrophy may affect the outcomes of patients treated with mechanical thrombectomy (MT) for large-vessel-occlusion because it is an indicator of low brain reserve. We performed a systematic literature review to assess the impact of brain atrophy on MT-related clinical outcomes.
METHODS: We conducted a systematic search of PubMed, MEDLINE, EMBASE, and Cochrane Library databases from inception to March 2021 using keywords with Boolean operators("brain atrophy"; "atrophy"; "white matter"; and "thrombectomy"). Articles published in English that evaluated the impact of pre-existing brain atrophy on outcomes of MT-treated acute ischemic stroke were eligible for inclusion.
RESULTS: Four articles were included. Brain atrophy index was a predictor of mortality (odds ratio [OR]:1.81-1.87, 95% confidence interval [CI]:1.16-2.93) after adjustments for age and white matter lesions. Global cortical atrophy scale was an independent predictor of futile recanalization (OR 1.15, 95% CI 1.08-1.22) in multivariate-adjusted logistic regression. Automated measurement of CSF identified increasing volumes associated with reduced 3-month functional independence and higher modified Rankin scale scores. STandards for ReportIng Vascular changes on Neuroimaging criteria for brain atrophy were associated with unfavorable outcome in ordinal-shift analysis (OR 2.72, 95% CI 1.25-5.91).
CONCLUSIONS: The few studies available highlight heterogeneity of neuroimaging methodologies for assessing brain atrophy and difficulty addressing the multiple confounders involved in clinical outcomes. More consistent, accurate investigation is needed before proposing brain atrophy as a possible parameter to improve patient selection for MT.
ADVANCES IN KNOWLEDGE: Brain atrophy is associated with many of the clinical confounders frequently present in patients with acute ischemic stroke. Heterogeneity in classification methodologies for brain atrophy and complexity analyzing multiple clinical confounders make it difficult to assess the true impact of this radiological finding on MT-related outcomes.
引用
- Monteiro, Waqas, Rai, et al. The impact of brain atrophy on the outcomes of mechanical thrombectomy. Br J Radiol. 2022. PMID: 35084207. doi:10.1259/bjr.20210494
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。